v3.24.1.u1
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Premiums $ 11,603 $ 11,025
Net investment income 290 277
TOTAL REVENUES 57,255 46,517
Benefits and expenses    
Pharmacy and other service costs 41,431 31,459
Medical costs and other benefit expenses 9,440 9,046
Selling, general and administrative expenses 3,705 3,538
Amortization of acquired intangible assets 423 459
TOTAL BENEFITS AND EXPENSES 54,999 44,502
Income from operations 2,256 2,015
Interest expense and other (322) (358)
Loss on sale of businesses (19) 0
Net realized investment losses (1,836) (56)
Income before income taxes 79 1,601
TOTAL INCOME TAXES 291 295
Net (loss) income (212) 1,306
Less: Net income attributable to noncontrolling interests 65 39
SHAREHOLDERS' NET (LOSS) INCOME $ (277) $ 1,267
Shareholders' net (loss) income per share    
Basic (in dollars per share) $ (0.97) $ 4.28
Diluted (in dollars per share) $ (0.97) $ 4.24
Pharmacy revenues    
Revenues    
Revenues $ 42,036 $ 32,144
Fees and other revenues    
Revenues    
Revenues $ 3,326 $ 3,071